Communication of socioeconomic research findings

PharmacoEconomics

Volumn 16, Issue SUPPL. 1, 1999, Pages 7-17

  Milne, Richard J ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Health Outcomes Associates Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DECISION MAKING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PRIORITY JOURNAL; SOCIOECONOMICS;

BIBLIOMETRICS; COMMUNICATION; DISEASE; ECONOMICS, PHARMACEUTICAL; HUMANS; PERIODICALS; RESEARCH; SOCIOECONOMIC FACTORS;

EID: 0032756001     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916001-00002     Document Type: Conference Paper

References (18)

1. Nichol KL. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmacoeconomics 1999; 16 Suppl. 1: 63-71
2. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey-Whitney Books Company, 1996
3. Kozma CM, Reeder CE, Schulz RM. Economic, clinical and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993; 15 (6); 1121-32
4. Rennie D. The present state of medical journals. Lancet 1998; 175 (352): SII18-22
5. Milne RJ. Pharmacoeconomic models in disease management. Dis Manage Health Outcomes 1998; 4 (3): 119-34
6. Lundberg GD. A Christmas fairy tale. BMJ 1996; 131: 1612
7. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
8. Basskin LE. Practical pharmacoeconomics. How to design, perform and analyze outcomes research. Cleveland, Ohio: Advanstar Communications Inc., 1998
9. Drummond MF, Jefferson TO, for the Working Party on Guidelines for Authors and Peer Reviewers of Economic Submissions to the British Medical Journal. Guidelines for authors and peer-reviewers of economic submissions to the British Medical Journal, BMJ 1996; 313: 275-383
10. Jefferson TO, Smith R, Yee Y, et al. Evaluating the BMJ guidelines for economic submissions. Prospective audit of economic submissions to BMJ and The Lancet. JAMA 1998; 280 (3): 275-7
11. Bradley CA, Iskedjian M, Lanctot KL, et al. Quality assessment of economic evaluations published in pharmacy, medical and health economics journals. Ann Pharmacother 1995; 29: 681-9
12. Iskedjian M, Trakas K, Bradley C, et al. Quality assessment of economic evaluations published in Pharmacoeconomics; the first 4 years. Pharmacoeconomics 1997; 12 (6): 685-94
13. Kassirer JP, Angell M. The journal's policy on cost-effectiveness analyses. N Engl J Med 1994; 331: 669-70
14. Gold MR, Siegel JE, Russell LB, et al. Cost effectiveness in health and medicine. Oxford: Oxford University Press, 1996
15. Delamothe T. Electronic preprints: what should the BMJ do? [editorial]. BMJ 1998; 316 (7134): 794-5
16. Kassirer JP, Angell M. The Internet and the Journal. N Engl J Med 1995; 332 (5): 1709-10
17. Nichol KJ, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in Ihe community. N Engl J Med 1994; 331: 778-84
18. Scott WG, Scott HM, Economic evaluation of vaccination against influenza in New Zealand. Pharmacoeconomics 1996; 9 (1): 51-60